Ad
Tuesday, 8 November 2016
Internal watchdog told Medicare, Medicaid centers EpiPen was misclassified in 2009
WASHINGTON (Reuters) - The internal watchdog at the U.S. Department of Health and Human Services warned the office tasked with administering federal health insurance programs that Mylan NV's EpiPen was improperly classified as a generic drug in 2009, Senator Charles Grassley said Tuesday.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment